UPDATED May 01, 2024
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2330 | NT$775.00 | 1.2% | 55.6% | NT$20.5t | NT$912.98 | PE23.5x | E16.1% | 1.8% | Semiconductors | ||
AZN | UK£121.70 | 7.2% | 2.4% | UK£188.7b | UK£131.45 | PE37.2x | E16.6% | 2.0% | Pharmaceuticals & Biotech | ||
NOVN | CHF89.05 | -0.08% | -3.7% | CHF181.7b | CHF99.70 | PE21.7x | E10.1% | 3.7% | Pharmaceuticals & Biotech | ||
ROG | CHF220.60 | -0.7% | -21.5% | CHF178.0b | CHF279.06 | PE15.3x | E8.8% | 4.4% | Pharmaceuticals & Biotech | ||
SAF | €204.20 | -2.9% | 46.3% | €84.4b | €210.37 | PE24.5x | E7.1% | 1.1% | Capital Goods | ||
ZURN | CHF444.20 | -0.5% | 3.7% | CHF64.0b | CHF462.29 | PE16x | E8.9% | 5.9% | Insurance | ||
SLB | US$47.16 | -4.0% | 4.2% | US$67.9b | US$66.69 | PE15.5x | E15.3% | 2.3% | Energy | ||
NTES | US$94.02 | 0% | 6.9% | US$60.2b | US$132.98 | PE14.9x | E7.9% | 2.7% | Media | ||
300760 | CN¥304.59 | 6.8% | -3.3% | CN¥368.4b | CN¥394.25 | PE30.3x | E15.0% | 1.9% | Healthcare | ||
2454 | NT$1,010.00 | 3.0% | 51.2% | NT$1.6t | NT$1,199.10 | PE20.9x | E13.3% | 6.0% | Semiconductors | ||
BBRI | Rp4,940.00 | -4.1% | -4.1% | Rp744.9t | Rp6,295.50 | PB2.5x | E10.1% | 6.5% | Banks | ||
BMRI | Rp6,900.00 | -0.7% | 33.3% | Rp644.0t | Rp7,586.28 | PB2.7x | E10.2% | 5.1% | Banks | ||
2020 | HK$90.95 | 2.2% | -2.9% | HK$254.1b | HK$112.00 | PE23.3x | E12.9% | 2.5% | Consumer Durables | ||
EVO | kr1,232.00 | -2.4% | -5.2% | kr260.0b | kr1,490.64 | PE20.3x | E12.4% | 2.5% | Consumer Services | ||
300274 | CN¥103.35 | 6.7% | -8.5% | CN¥151.8b | CN¥130.67 | PE15.1x | E11.2% | 0.9% | Capital Goods | ||
KCHOL | ₺226.10 | 6.7% | 198.5% | ₺573.4b | ₺215.07 | PE7.9x | E26.5% | 3.5% | Capital Goods | ||
NESTE | €21.34 | -17.4% | -50.3% | €16.4b | €33.80 | PE12.1x | E15.5% | 5.6% | Energy | ||
SOON | CHF255.40 | 0.08% | -9.9% | CHF15.2b | CHF270.88 | PE25.4x | E10.7% | 1.8% | Healthcare | ||
ALL | AU$39.02 | -5.0% | 2.1% | AU$24.9b | AU$47.49 | PE17x | E5.1% | 1.7% | Consumer Services | ||
JMT | €19.35 | 3.9% | -14.8% | €12.2b | €23.51 | PE17.1x | E8.6% | 3.4% | Consumer Retailing | ||
300122 | CN¥35.10 | 2.6% | -33.7% | CN¥84.0b | CN¥62.47 | PE11.2x | E22.8% | 2.3% | Pharmaceuticals & Biotech | ||
600845 | CN¥41.03 | 3.1% | -7.7% | CN¥83.2b | CN¥49.57 | PE37.3x | E21.4% | 2.4% | Software | ||
DOX | US$83.36 | -3.9% | -7.4% | US$9.8b | US$104.90 | PE17.4x | E15.8% | 2.3% | Software | ||
ALV | US$120.43 | 2.1% | 42.6% | US$9.7b | US$130.74 | PE18.1x | E16.8% | 2.3% | Automobiles |